<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-056036</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Serum adiponectin concentration association with anthropometric, biochemical and blood pressure measures in a population with high cardiovascular risk</dc:title>
<dc:description xml:lang="en">Introduction. Serum adiponectin concentrations have been inversely associated with abdominal obesity, a more favorable lipid profile, and less insulin resistance. Nevertheless, recent studies in the population at high cardiovascular risk, especially that with altered renal function, show that high adiponectin concentrations are an unfavorable indicator. The aim of this study was to analyze the association of adiponectinemia with anthropometric, biochemical and blood pressure parameters in patients with high cardiovascular risk. Patients and methods. We studied 185 patients (133 women and 52 men), participating in the PREDIMED study (mean age 65.5 ± 4.3 years). Clinical, anthropometric, biochemical and blood pressure data, as well as adiponectinemia, were analyzed. Results. The body mass index was slightly higher in women than in men (31.1 ± 4.3 kg/m2 versus 29.4 ± 4.0 kg/m2; p = 0.01). The prevalence of diabetes was 42.2% and was higher in men (61.5%) than in women (34.6%). Adiponectin concentrations were higher in women than in men (11.0 ± 5.2 versus 6.9 ± 3.3 µg/mL; p &lt; 0.001). After adjustment for sex, mean adiponectin concentrations were higher in nondiabetic than in diabetic participants (10.3 ± 0.5 versus 7.5 ± 0.5; p &lt; 0.001). Positive correlations between adiponectin and high-density lipoprotein cholesterol were obtained (r = 0.36; p &lt; 0.001). Negative correlations with plasma triglycerides (r = ­0.28; p &lt; 0.001), glycemia (r = ­0,28; p &lt; 0.001) and plasma creatinine (r = ­0.28; p = 0.007) were found. No association was found between adiponectinemia and systolic or diastolic blood pressure. Conclusions. In the population studied with high cardiovascular risk, the correlations between adiponectinemia and anthropometric parameters and blood pressure were less clear than those in the general population. However, adiponectin concentrations were lower in diabetics and were inversely correlated with creatinine levels (AU)</dc:description>
<dc:creator>González, José Ignacio</dc:creator>
<dc:creator>Guillén, Marisa</dc:creator>
<dc:creator>Francés, Francesc</dc:creator>
<dc:creator>Godoy-Gijón, Elena</dc:creator>
<dc:creator>Carrasco, Paula</dc:creator>
<dc:creator>Sorlí, José Vicente</dc:creator>
<dc:creator>Ortega-Azorín, Carolina</dc:creator>
<dc:creator>Corella, Dolores</dc:creator>
<dc:creator>Saiz, Carmen</dc:creator>
<dc:creator>Pascual, Vicente</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. La adiponectinemia se ha asociado inversamente con obesidad abdominal, un perfil lipídico más favorable y menor resistencia a la insulina. Sin embargo, recientes estudios en población de alto riesgo cardiovascular, especialmente con función renal alterada, muestran que concentraciones elevadas son un indicador desfavorable. Nuestro objetivo ha sido estudiar la asociación entre adiponectinemia y parámetros antropométricos, bioquímicos y presión arterial (PA) en pacientes de alto riesgo cardiovascular. Pacientes y métodos. Se estudió a 185 pacientes (133 mujeres y 52 varones), participantes del estudio PREDIMED (edad media de 65,5 ± 4,3 años). Se obtuvieron datos clínicos, antropométricos, bioquímicos y de PA, así como adiponectinemia. Resultados. El índice de masa corporal (IMC) fue ligeramente superior en mujeres que en varones (31,1 ± 4,3 frente a 29,4 ± 4,0 kg/m2; p = 0,01). La prevalencia de diabetes fue del 42,2%, y era superior en los varones (61,5%) que en las mujeres (34,6%). La adiponectinemia fue superior en las mujeres que en los varones (11,0 ± 5,2 frente a 6,9 ± 3,3 µg/ml; p &lt; 0,001). Tras ajustar por sexo, las concentraciones medias de adiponectina fueron más elevadas en no diabéticos que en diabéticos (10,3 ± 0,5 frente a 7,5 ± 0,5; p &lt; 0,001). Se obtuvieron correlaciones positivas entre adiponectina y colesterol unido a lipoproteínas de alta densidad (cHDL) (r = 0,36; p &lt; 0,001), y correlaciones negativas con triglicéridos plasmáticos (r = ­0,28; p &lt; 0,001), glucemia (r = ­0,28; p &lt; 0,001) y creatinina plasmática (r = ­0,28; p = 0,007). Ni la PA sistólica ni la diastólica se asociaron con la adiponectinemia. Conclusiones. La adiponectinemia en esta población de alto riesgo cardiovascular no presenta correlaciones tan claras con parámetros antropométricos y PA como en población general. Sí que se ha mostrado más baja en diabéticos y correlacionada inversamente con la creatinina (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);19(4): 174-180, jul. 2007. ilus</dc:source>
<dc:identifier>ibc-056036</dc:identifier>
<dc:title xml:lang="es">Asociaciones de la concentración de adiponectina sérica con parámetros antropométricos, bioquímicos y presión arterial en población de alto riesgo cardiovascular</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d28903^s22062</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22032</dc:subject>
<dc:subject>^d24542</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d9951^s22032</dc:subject>
<dc:subject>^d33939^s22045</dc:subject>
<dc:subject>^d31672</dc:subject>
<dc:subject>^d27937</dc:subject>
<dc:subject>^d3942^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>200707</dc:date>
</metadata>
</record>
</ibecs-document>
